T. Lin, R. Ambasudhan, X. Yuan, W. Li, S. Hilcove, R. Abujarour, X. Lin, H. S. Hahm, E. Hao, A. Hayek, et al., “A chemical platform for improved induction of human iPSCs,” Nature Methods, Vol. 6, No. 11, pp. 805–808, 2009.

has been cited by the following article:

• TITLE: Transfusion of Ipscs-Derived Leukocytes to Kill Cancer

  AUTHORS: Jiang Li, Ying Cui, Guodong Gao, Ti-Fei Yuan

  KEYWORDS: Ipscs, Leukocytes, Cancer

  JOURNAL NAME: Journal of Cancer Therapy, Vol.1 No.1, March 25, 2010

  ABSTRACT: Here we propose that the rejuvenation of leukocytes with iPSC technology in vitro and transfusion of cancer cellresistant white blood cells back to human body provide a prospective therapy for cancer patients.